Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-17

Clinical Trial Update: Lamotrigine in Treatment Resistant Depression in Adolescents [NA]

View source ↗

Summary

A clinical trial evaluating lamotrigine for treatment-resistant depression in adolescents sponsored by MaineHealth has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamotrigine (lamotrigine)

Snippet

Sponsor: MaineHealth | Conditions: Adolescent Depression | NA | Status: TERMINATED